Jackley and attorneys general in 35 other states in April 2012 reached a $200 million settlement with Janssen Pharmaceuticals Inc. over allegations it marketed anti-psychotic drugs for non-approved uses.
Janssen did not admit wrongdoing, but it agreed not to promote the drugs for off-label use or make misleading claims.
South Dakota's share of the settlement was just under $2.6 million. Jackley on Monday said the money is funding treatment, education, training and outreach programs.
The state Consumer Protection Division and Department of Social Services determined the funding uses.
(Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)